Skip to main content

Disruptive Behavior clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Prazosin for Agitation in Alzheimer's Disease

    open to all eligible people

    The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion

    San Diego, California and other locations

Last updated: